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Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by proliferative synovitis with massive infiltration of lymphocytes, leading to destruction of cartilage, bone, and the joint structure (1). Immunogenetic studies have shown that genetic variations regarding T-cell-mediated immunity such as HLA-DRB1 shared epitope, PTPN22, and CTLA4 alleles are associated with RA (2) (3) (4) (5) , and T-cell-targeting treatments such as CTLA4-Ig are clinically effective (6) . These findings strongly suggest a key role of T cells in the pathogenesis of RA. Animal models have shown that T helper 1 (Th1) cells and T helper 17 (Th17) cells play crucial roles in various autoimmune diseases (7) (8) (9) . However, in rodent models of arthritis, deficiency in the interferon-γ (IFN-γ) receptor exacerbates the disease (10) , and anti-IFN-γ treatment produces an insufficient clinical effect in RA patients (11) . Although recent reports indicate a definite role of IL-17 in the pathogenesis of autoimmune arthritis in both animal models and human (9, 12, 13) , the contribution of Th17 cells to the pathogenesis of human RA is still controversial. Increased Th17 cell number is not obvious in RA patients (14) , and mast cells are considered the main source of human IL-17 rather than CD4+ T cells in RA synovial tissues (15, 16) . Taken together, previous findings imply that a CD4+ T cell subset other than Th1 or Th17 cells may also contribute to the pathogenesis of RA.
One striking feature of RA is that synovitis is accompanied by ectopic lymphoid (17, 18) . The chemokine CXCL13 plays a crucial role in the formation of germinal center (GC) (19) , and it has been reported that CXCL13 expression is elevated markedly in human RA synovitis (20) . In mice, CXCL13 is produced mainly by stromal cells such as follicular dendritic cells (FDCs) in the secondary lymphoid organs (SLO) (21) but not by T cells such as follicular helper T (Tfh) cells in the GC (22) . In 2008, Manzo et al. showed that CD4+ T cells of RA synovitis appear to produce CXCL13 spontaneously, and stimulation with anti-CD3/CD28 antibodies enhances ongoing CXCL13 production (23) . Although these cells were shown to be negative for CXCR5 and BCL6, both hallmarks of Tfh cells, further relevance to known Th subsets such as Th1, Th17 or Tfh cell has been still unclear. Indeed, reports have shown that some subsets of human CD4+ T cells express CXCL13. Tonsillar CXCR5+ Tfh cells, which are positive for BCL6 as a nuclear marker of Tfh, express CXCL13 (24) . Another study showed that human Th17 clones preferentially produce CXCL13 (25) .
Here we show that CXCL13-producing CD4+ T cells in RA synovitis are a CD4 subset distinct from Th1, Th2, Th17, CXCR5+ Tfh, and Treg cells, and that proinflammatory cytokines and TCR stimulation are involved in long-term production of CXCL13 by this subset. Furthermore, T cell receptor (TCR) stimulation of blood CD4+ T cells from healthy volunteers together with proinflammatory cytokines Synovial tissues and tonsils were minced and digested with 2.5 mg/ml collagenase (Roche) at 37°C for 1.5 h and then analyzed.
Peripheral blood mononuclear cells (PBMCs) or synovial fluid mononuclear cells (SFMCs) were collected using Lymphocyte Separation Solution 1.077 (Nacalai Tesque). Because stimulation with PMA and ionomycin reduced the production of CXCL13, we optimized the concentrations of PMA and ionomycin to detect the production of CXCL13, IFN-γ, and IL-17 simultaneously (see Supplementary Figure 1 
CD4+ T cells were sorted with a CD4+ T Cell isolation kit (Miltenyi Biotec
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Statistical analysis. The data were analyzed using Student's t test or Especially, ICOS deficient humans have profound deficits in antibody production, class switch, GC formation, and the presence of circulating CXCR5+CD45RO+CD4+ T cells (27) . Synovial CXCL13+CD4+ T cells are similar to Tfh cells in that both cell types express high levels of PD-1 ( Figure 1D ) (30) We designate the T cell subset as inflammatory CXCL13-producing helper T (iTh13) cells.
CD4 subsets such as Th1, Th2, and Th17 cells produce cytokines promptly upon TCR stimulation. We demonstrated that the CXCX13-producing CD4 subset also can be in a memory state ready to produce CXCL13 upon TCR stimulation and that proinflammatory cytokines support their long-term production of CXCL13 ( Figure 4B ).
By contrast, the amount of IFN-γ is relatively small (33) , and mast cells rather than CD4+ T cells are a main source of IL-17 in RA synovitis (15) . Taken CXCL13 is expressed in ectopic lymphoid structures including islets of NOD mice, the aorta of ApoE deficient mice, and synovial tissues of RA patients (23, 36, 37) , and the ectopic expression of CXCL13 is sufficient to generate ectopic lymphoid structures (38) . While medial smooth muscle cells produce CXCL13 in ApoE deficient mice (37) , histologic analysis previously showed that both stromal and T cells produce 
